Figure 3.

Kaplan-Meier curves for patients with advanced hepatocellular carcinoma and main portal vein tumor thrombosis for the T+S and S groups. (A): Patients with CP-5: The median OS for T+S group (n = 21) and the S group (n = 23) was 8.0 months and 7.5 months, respectively (p = .669). (B): Patients with CP-6: The median OS for the T+S group (n = 12) and the S group (n = 11) was 6.5 months and 8.0 months, respectively (p = .778). (C): Patients with CP-7: The median OS for the T+S group and the S group (n = 10 for both) was 3.0 months and 5.0 months, respectively (p = .233).

Abbreviations: CP, Child-Pugh score; OS, overall survival; S, sorafenib monotherapy; T+S, combination sorafenib plus transarterial chemoembolization.